How will Decentralized Clinical Trials (DCT) Dominate 2021

2 min read

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on email

Introduction:

Decentralized clinical trials or DCT have become the new norm for the life sciences industry, particularly the clinical trial domain. The introduction of DCT has improved the flexibility of clinical trial research alongside the discovery of the potential for bringing all clinical research stakeholders on a single page. So, DCT will have a formidable impact on shaping up the clinical trial landscape in 2021 in various aspects.

Here in this blog, we have discussed 5 ways in which decentralized trials will change the clinical research space.

  • The flexibility of the modular framework in the decentralized model

The modular framework in DCT can help patients, sponsors, clinical sites, and other stakeholders in the trial in accessing a wide range of options. So, new clinical research ventures could capitalize on the opportunities for easy configuration and personalization of alternatives for engagement.

  • Virtual tools will bring patients closer to clinical trials

The decentralized model can also help in resolving concerns of racial discrimination in healthcare alongside improving overall access to clinical trials. The use of technology, especially virtual tools, can help in removing the unnecessary complications of traveling and distance.

Most important of all, the improved integration of technology in the decentralized model can also promote the integration of diversity as a staple in the processes of clinical study protocol design and initial product development.

  • Research sites can overcome their uncertainties through decentralized solutions

Research sites are most likely to hold apprehension even if the pharma industry sustains the pace of adopting DCT models. However, the better standards of patient care through the use of DCT model in clinical trials can motivate other research sites to follow the same path.

Some of the key highlights include the facility for clinical trial patients to stay at their homes and obtain access to revolutionary new therapies under the supervision of a physician.

  • Decentralized solutions enable proactive identification of critical symptoms 

The data collection efficiency in DCT platforms can help in the proactive identification of indications about the potential adverse events in a clinical trial. The indications, otherwise known as digital biomarkers, can promote better measures for patient care and the integrity of significant clinical trials.

  • Enables flexible access translates to trial effectiveness for clinical trials

Finally, it is important to look at the flexibility aspect of the DCT model once again as it can promote better access for all stakeholders. Subsequently, improved collaboration among stakeholders can ensure prolific outcomes such as faster patient enrolment and better retention rates.

Conclusion:

With multiple benefits associated with decentralized clinical trial solutions,  it is important to consider the ideal technology vendors to support clinical trial ventures in bridging the gaps to implementation of DCT model in their operations.

A comparative analysis to understand the value propositions offered is mandatory for rational decision-making rather than being bait to marketing jargon.

Subscribe to our weekly newsletter

Request a demo specialized to your need.

Share this blog:

Share on linkedin
Share on twitter
Share on facebook
Share on email

Request a demo specialized to your need.

Prioritizing Communication Through an Integrated CTMS

Related Resources

Data management in a cloud-based world

Over the years, technology has made its way into different aspects of clinical trials bringing in significant progress in the field. There is no denying that in a

Cloudbyz eConsent

With increasing complexity in clinical trials and the adoption of virtual trials, ensuring patients and subjects have a clear understanding of what they will encounter and experience when

Cloudbyz - Safety & Pharmacovigilance Solution Overview

Disparate systems can cause preventable delays in periodic and AE/SAE reporting, which can

Clinical Trial Budget Management

Clinical trials are performed to demonstrate the safety and efficacy of the new drug, improve the capabilities of known drugs.

Cloudbyz is focused on building innovative enterprise applications and solutions natively on the cloud to help enterprises be innovative and agile.

4320 Winfield Road, Suite 200
Warrenville, IL 60555, The USA
Phone: +1 (312)-763-8040
Email: info@cloudbyz.com

Subcribe to our newsletter

Get the latest update from us by subscribing to our newsletter.

© 2021 Cloudbyz